COCRYSTAL PHARMA, INC. Prepaid Expense and Other Assets, Current
COCRYSTAL PHARMA, INC. (COCP) had Prepaid Expense and Other Assets, Current of $256.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $256.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $418.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $328.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $465.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $256.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $418.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $328.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $465.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $282.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $385.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $430.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $509.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $365.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.57M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.77M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.84M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.06M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.22M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.24M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $2.77M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $488.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $560.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $568.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $747.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $225.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $363.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $399.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $487.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $145.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $202.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $169.00K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $201.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $95.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $169.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $191.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $278.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $229.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $203.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $105.00K 10-K · filed 2019-04-01 | $104.00K 10-K · filed 2018-03-21 |
| 2017-09-30 | $240.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $196.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $251.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $517.00K 10-K · filed 2018-03-21 | |
| 2016-09-30 | $625.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $688.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $486.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $441.00K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $632.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $364.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $192.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $144.00K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $116.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $156.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $153.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $139.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $207.66K 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $202.53K 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $188.93K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $17.71K 10-K · filed 2014-03-31 | $121.91K 10-K · filed 2013-04-01 |
| 2012-09-30 | $489.66K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $562.06K 10-Q/A · filed 2012-09-28 | |
| 2012-03-31 | $381.23K 10-Q/A · filed 2012-10-02 | |
| 2011-12-31 | $145.31K 10-K · filed 2013-04-01 | |
| 2011-09-30 | $60.22K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $94.38K 10-Q/A · filed 2011-09-09 | |
| 2010-12-31 | $43.28K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |